CUSIP: 29363K105
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,137,989
-
Share change
-
+349,948
-
Total reported value
-
$220,671,000
-
Price per share
-
$18.19
-
Number of holders
-
55
-
Value change
-
+$7,004,783
-
Number of buys
-
29
-
Number of sells
-
14
Quarterly Holders Quick Answers
What is CUSIP 29363K105?
CUSIP 29363K105 identifies ENTL - ENTELLUS MED INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP 29363K105:
Institutional Holders of ENTELLUS MED INC - COM (ENTL) as of Q1 2016
As of 31 Mar 2016,
ENTELLUS MED INC - COM (ENTL) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,137,989 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., SV Life Sciences Advisers, LLC, FMR LLC, WELLS FARGO & COMPANY/MN, Murphy Michael R, First Light Asset Management, LLC, Cortina Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, KINGDON CAPITAL MANAGEMENT, L.L.C., and VANGUARD GROUP INC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.